JP2013523706A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013523706A5 JP2013523706A5 JP2013501934A JP2013501934A JP2013523706A5 JP 2013523706 A5 JP2013523706 A5 JP 2013523706A5 JP 2013501934 A JP2013501934 A JP 2013501934A JP 2013501934 A JP2013501934 A JP 2013501934A JP 2013523706 A5 JP2013523706 A5 JP 2013523706A5
- Authority
- JP
- Japan
- Prior art keywords
- crystalline
- benzylcarbamoyl
- dimethylamide
- ylcarbonyl
- proline
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000634 powder X-ray diffraction Methods 0.000 description 5
- RUOLFWZIFNQQGH-DEOSSOPVSA-N (2s)-2-n,2-n-dimethyl-1-n-[[2-methyl-4-(2,3,4,5-tetrahydro-1-benzazepine-1-carbonyl)phenyl]methyl]pyrrolidine-1,2-dicarboxamide Chemical compound CN(C)C(=O)[C@@H]1CCCN1C(=O)NCC1=CC=C(C(=O)N2C3=CC=CC=C3CCCC2)C=C1C RUOLFWZIFNQQGH-DEOSSOPVSA-N 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 3
- -1 2-Methyl-4- (2,3,4,5-tetrahydro-1-benzazepin-1-ylcarbonyl) benzylcarbamoyl Chemical group 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 238000002441 X-ray diffraction Methods 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000000113 differential scanning calorimetry Methods 0.000 description 1
- QKIUAMUSENSFQQ-UHFFFAOYSA-N dimethylazanide Chemical compound C[N-]C QKIUAMUSENSFQQ-UHFFFAOYSA-N 0.000 description 1
- 150000004677 hydrates Chemical class 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000012453 solvate Substances 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1005623.2A GB201005623D0 (en) | 2010-04-01 | 2010-04-01 | New polymorph |
| GB1005623.2 | 2010-04-01 | ||
| US34704810P | 2010-05-21 | 2010-05-21 | |
| US61/347,048 | 2010-05-21 | ||
| PCT/GB2011/000500 WO2011121308A1 (en) | 2010-04-01 | 2011-03-31 | New polymorph |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013523706A JP2013523706A (ja) | 2013-06-17 |
| JP2013523706A5 true JP2013523706A5 (enExample) | 2015-05-14 |
| JP5802737B2 JP5802737B2 (ja) | 2015-11-04 |
Family
ID=42228830
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013501934A Expired - Fee Related JP5802737B2 (ja) | 2010-04-01 | 2011-03-31 | 新規な多形体 |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US9079881B2 (enExample) |
| EP (1) | EP2552910B1 (enExample) |
| JP (1) | JP5802737B2 (enExample) |
| KR (1) | KR101792621B1 (enExample) |
| CN (1) | CN102918038B (enExample) |
| CA (1) | CA2795109C (enExample) |
| DK (1) | DK2552910T3 (enExample) |
| ES (1) | ES2538085T3 (enExample) |
| GB (1) | GB201005623D0 (enExample) |
| HR (1) | HRP20150513T1 (enExample) |
| HU (1) | HUE026442T2 (enExample) |
| ME (1) | ME02102B (enExample) |
| MX (1) | MX2012011382A (enExample) |
| PL (1) | PL2552910T3 (enExample) |
| PT (1) | PT2552910E (enExample) |
| RS (1) | RS53956B1 (enExample) |
| RU (1) | RU2559633C2 (enExample) |
| SI (1) | SI2552910T1 (enExample) |
| SM (1) | SMT201500107B (enExample) |
| WO (1) | WO2011121308A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201105537D0 (en) * | 2011-03-31 | 2011-05-18 | Vantia Ltd | New process |
| CN103755707B (zh) * | 2013-09-17 | 2015-11-18 | 天津药物研究院 | 利希普坦晶型ⅱ及其制备方法和用途 |
| CN104059070B (zh) * | 2013-09-17 | 2016-02-10 | 天津药物研究院有限公司 | 利希普坦晶型ⅰ及其制备方法和用途 |
| CN103694240B (zh) * | 2013-09-18 | 2015-11-18 | 天津药物研究院 | 利希普坦的溶剂合物及其制备方法和用途 |
| CN104140429B (zh) * | 2014-07-25 | 2015-11-18 | 天津药物研究院 | 利希普坦晶型ⅴ及其制备方法和用途 |
| JP7304043B2 (ja) * | 2015-07-22 | 2023-07-06 | アナベックス ライフ サイエンシズ コーポレイション | テトラヒドロ－ｎ，ｎ－ジメチル－２，２－ジフェニル－３－フランメタンアミンヒドロクロリドの結晶形態、かかる形態の作製方法およびその薬学的組成物 |
| WO2020154581A1 (en) | 2019-01-24 | 2020-07-30 | Assia Chemical Industries Ltd | Solid state forms of fedovapagon-salicyclic acid co-crystal |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW359669B (en) | 1995-12-15 | 1999-06-01 | Otsuka Pharma Co Ltd | Benzazepine derivatives |
| CN1183134C (zh) | 1997-07-30 | 2005-01-05 | 惠氏公司 | 三环后叶加压素激动剂 |
| JP2001512120A (ja) | 1997-07-30 | 2001-08-21 | アメリカン・ホーム・プロダクツ・コーポレイション | 三環系バソプレシンアゴニスト |
| CA2358894A1 (en) | 1999-02-04 | 2000-08-10 | American Home Products Corporation | Tricyclic pyridine n-oxides vasopressin agonists |
| AU2603000A (en) | 1999-02-04 | 2000-08-25 | American Home Products Corporation | Thienylbenzoylbenzazepines as vasopressin agonists |
| CN1339035A (zh) | 1999-02-04 | 2002-03-06 | 美国家用产品公司 | 吡啶并苯并二吖庚因和吡啶并苯并氧杂吖庚因酰胺血管加压素激动剂 |
| DE60000969D1 (de) | 1999-02-04 | 2003-01-23 | Wyeth Corp | Pyrrolobenzodiazepine carboxamide vasopressin agonisten |
| GB0000079D0 (en) * | 2000-01-05 | 2000-02-23 | Ferring Bv | Novel antidiuretic agents |
| GB0015601D0 (en) * | 2000-06-26 | 2000-08-16 | Ferring Bv | Novel antidiuretic agents |
-
2010
- 2010-04-01 GB GBGB1005623.2A patent/GB201005623D0/en not_active Ceased
-
2011
- 2011-03-31 WO PCT/GB2011/000500 patent/WO2011121308A1/en not_active Ceased
- 2011-03-31 ES ES11714079.8T patent/ES2538085T3/es active Active
- 2011-03-31 KR KR1020127028111A patent/KR101792621B1/ko not_active Expired - Fee Related
- 2011-03-31 CA CA2795109A patent/CA2795109C/en not_active Expired - Fee Related
- 2011-03-31 US US13/637,873 patent/US9079881B2/en not_active Expired - Fee Related
- 2011-03-31 DK DK11714079T patent/DK2552910T3/en active
- 2011-03-31 PT PT117140798T patent/PT2552910E/pt unknown
- 2011-03-31 RS RS20150258A patent/RS53956B1/sr unknown
- 2011-03-31 HR HRP20150513TT patent/HRP20150513T1/hr unknown
- 2011-03-31 MX MX2012011382A patent/MX2012011382A/es active IP Right Grant
- 2011-03-31 HU HUE11714079A patent/HUE026442T2/en unknown
- 2011-03-31 ME MEP-2015-56A patent/ME02102B/me unknown
- 2011-03-31 PL PL11714079T patent/PL2552910T3/pl unknown
- 2011-03-31 RU RU2012146544/04A patent/RU2559633C2/ru not_active IP Right Cessation
- 2011-03-31 JP JP2013501934A patent/JP5802737B2/ja not_active Expired - Fee Related
- 2011-03-31 EP EP11714079.8A patent/EP2552910B1/en active Active
- 2011-03-31 CN CN201180026714.4A patent/CN102918038B/zh not_active Expired - Fee Related
- 2011-03-31 SI SI201130487T patent/SI2552910T1/sl unknown
-
2015
- 2015-05-05 SM SM201500107T patent/SMT201500107B/xx unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013538253A5 (enExample) | ||
| JP2012531408A5 (enExample) | ||
| HRP20151299T1 (hr) | Kristalni (r)-(e)-2-(4-(2-(5-(1-(3,5-diklorpiridin-4-il)etoksi)-1h-indazol-3-il)vinil)-1h-pirazol-1-il)etanol i njegova upotreba kao inhibitora fgfr | |
| JP2009235086A5 (enExample) | ||
| FI3102208T4 (fi) | 2-hydroksi-6-((2-(1-isopropyyli-1h-pyratsol-5-yyli)pyridin-3-yyli)metoksi)bentsaldehydin vapaan emäksen kiteinen polymorfi | |
| JP2016041720A5 (enExample) | ||
| ES2613716T3 (es) | Formas cristalinas de un derivado de purina | |
| PH12015502825B1 (en) | Crystals | |
| UA97478C2 (ru) | Кристаллическая форма vi агомелатина, способ ее приготовления (варианты) и фармацевтическая композиция, которая ее содержит | |
| AR091138A1 (es) | Proceso para la preparacion de n-[5-(3,5-difluorobencil)-1h-indazol-3-il]-4-(4-metilpiperazin-1-il)-2-(tetrahidropiran-4-ilamino)-benzamida | |
| JP2011249742A5 (enExample) | ||
| JP2016065042A5 (enExample) | ||
| JP2013521273A5 (enExample) | ||
| PL2311805T3 (pl) | Nowa postać polimorficzna octanu bazedoksyfenu | |
| JP2013010749A5 (ja) | カルバゾール化合物 | |
| JP2012235145A5 (enExample) | ||
| TWI456822B (zh) | 鋰離子蓄電池用正極活性物質 | |
| JP2016505498A5 (enExample) | ||
| JP2007532560A5 (enExample) | ||
| NO20063516L (no) | Ny krystallinsk form III av agomelatin, fremgangsmate for dens fremstilling og farmasoytiske sammensetninger inneholdende den | |
| JP2016503749A5 (enExample) | ||
| JP2011242375A5 (enExample) | ||
| JP2009167413A5 (enExample) | ||
| JP2015506941A5 (enExample) | ||
| HRP20220031T1 (hr) | Kristalni trihidratni oblik (3s,3s') 4,4'-disulfanedilbis (3-aminobutan 1-sulfonske kiseline) |